[e-farmacos] Br J Clin Pharmacol: agenda grupo RA de Cochrane Collabor.

["Madurga, Mariano" <mmadurga@agemed.es>]

Estimadas y estimados amigos,

En el numero de agosto 2007 de la revista British Journal of Clinical Pharmacology,  su editor  Dr Aronson, aprovecha la publicacion de varios articulos en este numero, para incluir un editorial: "An agenda for research on adverse drug reactions". Expone los pasos dados por un Grupo de Expertos creado como parte de la Colaboracion Cochrane (www.cochrane.org/contact/mwgfield.htm) desde hace dos anos. Pretende desarrollar e implementar metodos de revision sistematica de las RA de intervenciones terapeuticas. Finalmente comenta los pasos programados por el Grupo para esta actividad, ofreciendo la posibilidad de incorporarse a los voluntarios que quieran compartir trabajo con el Grupo (A Herxheimer, Y Loke, S Golder, JK Aronson)

Este articulo de acceso libre, en: http://www.blackwell-synergy.com/doi/full/10.1111/j.1365-2125.2007.03014.x
 
Se recomienda revisar el numero completo por los diferentes e interesantes articulos que se incluyen, no solo sobre RA, sino sobre lo llamado hoy en dia 'creadores de enfermedades' por Dear & Webb (paginas 122-124). 
Esta es una seleccion del indice:

Commentary

 Disease mongering - a challenge for everyone involved in healthcare 
James W. Dear & David J. Webb
pages 122-124

Pharmacokinetics & pharmacodynamics

An integrated model for the effect of budesonide on ACTH and cortisol in healthy volunteers 

Anna Lönnebo Anders Grahnén & Mats O. Karlsson
pages 125-132

Flavonoids inhibit the platelet TxA2 signalling pathway and antagonize TxA2 receptors (TP) in platelets and smooth muscle cells 

José A. Guerrero, Leyre Navarro-Nuñez, María L. Lozano, Constantino Martínez, Vicente Vicente, Jonathan M. Gibbins & José Rivera
pages 133-144

Nitroglycerin protects the endothelium from ischaemia and reperfusion: human mechanistic insight 

Tommaso Gori Giuseppe Di Stolfo Silvia Sicuro Saverio Dragoni Monica Lisi Sandro Forconi & John D. Parker
pages 145-150

Pharmacokinetics

Population pharmacokinetics of melphalan in paediatric blood or marrow transplant recipients 

Christa E. Nath Peter J. Shaw Kay Montgomery & John W. Earl
pages 151-164
 

Effect of renal impairment on the pharmacokinetics of bupropion and its metabolites 

Miia Turpeinen Niina Koivuviita Ari Tolonen Petri Reponen Stefan Lundgren, Jouko Miettunen, Kaj Metsärinne Anders Rane Olavi Pelkonen & Kari Laine
pages 165-173
  

Desloratadine dose selection in children aged 6 months to 2 years: comparison of population pharmacokinetics between children and adults 

Samir K. Gupta, Bhavna Kantesaria, Christopher Banfield & Zaiqi Wang
pages 174-184

Pharmacogenetics

Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects 

Ji H. Choi, Yoon J. Lee, Seong B. Jang, Jong-Eun Lee Kyung H. Kim & Kyungsoo Park
pages 185-191

Drug safety

Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases 

C. Howell, A. D. Wilson & W. S. Waring
pages 192-197
  

Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey 

Caroline Victorri-Vigneau, Eric Dailly, Gwenaëlle Veyrac & Pascale Jolliet
pages 198-209

Carisoprodol use and abuse in Norway. A pharmacoepidemiological study 

Jørgen G. Bramness Kari Furu Anders Engeland & Svetlana Skurtveit
pages 210-218
 

Short reports

Perception of risk of adverse drug reactions by medical students: influence of a 1 year pharmacological course 

G. Durrieu C. Hurault V. Bongard C. Damase-Michel & J. L. Montastruc
pages 233-236

Dihydropyrimidine dehydrogenase activity and the IVS14+1G>A mutation in patients developing 5FU-related toxicity 

Nicolas Magné Marie-Christine Etienne-Grimaldi Laurent Cals Nicole Renée Jean-Louis Formento Mireille Francoual & Gérard Milano
pages 237-240

Letters to the editors
Safety of amlodipine use in patients with acute intermittent porphyria 

Hakan Cinemre, Ugur Korkmaz, Aytekin Alcelik, Elif Onder & Adem Gungor
pages 246-247
	
Un  abrazo,
	
Mariano Madurga
AEMPS, Div FEpi y FV
mmadurga@agemed.es